Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape
2022 · The Lancet Infectious Diseases · 414 citations
https://doi.org/10.1016/s1473-3099(22)00291-2
Y
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
155
Papers
8.8K
Citations
39
h-index
81
i10-index
Youyi Fong is an academic researcher from Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa. The author has contributed to research in topics: SARS-CoV-2 and COVID-19 Research & HIV Research and Treatment & COVID-19 Clinical Research Studies. The author has an h-index of 39, co-authored 132 publications.
ORCID: 0000-0002-4230-6863Papers by this author
worksImproving random forest predictions in small datasets from two-phase sampling designs
2021 · BMC Medical Informatics and Decision Making · 120 citations
https://doi.org/10.1186/s12911-021-01688-3
HLA class II genes modulate vaccine-induced antibody responses to affect HIV-1 acquisition
2015 · Science Translational Medicine · 53 citations
https://doi.org/10.1126/scitranslmed.aab4005
HAI and NAI titer correlates of inactivated and live attenuated influenza vaccine efficacy
2019 · BMC Infectious Diseases · 40 citations
https://doi.org/10.1186/s12879-019-4049-5
HIV-Exposed Infants Vaccinated with an MF59/Recombinant gp120 Vaccine Have Higher-Magnitude Anti-V1V2 IgG Responses than Adults Immunized with the Same Vaccine
2017 · Journal of Virology · 35 citations
https://doi.org/10.1128/jvi.01070-17
Quality control, analysis and secure sharing of Luminex® immunoassay data using the open source LabKey Server platform
2013 · BMC Bioinformatics · 17 citations
https://doi.org/10.1186/1471-2105-14-145
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat